Posttreatment plasma VEGF levels may be associated with the overall survival of patients with advanced non-small cell lung cancer treated with bevacizumab plus chemotherapy.

SJ, An; YS, Huang; ZH, Chen; J, Su; Y, Yang; JG, Chen; HH, Yan; QX, Lin; JJ, Yang; XN, Yang

doi:10.1007/s12032-011-9924-x

Posttreatment plasma VEGF levels may be associated with the overall survival of patients with advanced non-small cell lung cancer treated with bevacizumab plus chemotherapy.

NobleIDNI9P90W70R33S97

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/393D97D1.svg?ark=w1%2F20260526%2F393D97D1&value=id)](https://nobleid.org/work/w1/20260526/393D97D1)

ARK Inflections

Metadata (JSON)Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Posttreatment plasma VEGF levels may be associated with the overall survival of patients with advanced non-small cell lung cancer treated with bevacizumab plus chemotherapy.

NobleIDNI9P90W70R33S97

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/393D97D1.svg?ark=w1%2F20260526%2F393D97D1&value=id)](https://nobleid.org/work/w1/20260526/393D97D1)

ARK Inflections

Metadata (JSON)Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work